Management strategies for nephrotoxicity.
MacDonald
A S
AS
D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000627:therapeutic use / Q000633:toxicity; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000188:drug therapy; D016559:Tacrolimus / Q000627:therapeutic use / Q000633:toxicity
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus